KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Interest Expenses (2018 - 2019)

Acadia Pharmaceuticals has reported Interest Expenses over the past 2 years, most recently at $12000.0 for Q2 2019.

  • Quarterly results put Interest Expenses at $12000.0 for Q2 2019, down 95.14% from a year ago — trailing twelve months through Mar 2020 was $12000.0 (down 99.42% YoY), and the annual figure for FY2018 was $1.8 million, changed.
  • Interest Expenses for Q2 2019 was $12000.0 at Acadia Pharmaceuticals, down from $229000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for ACAD hit a ceiling of $1.7 million in Q3 2018 and a floor of -$127000.0 in Q4 2018.